Mercado mundial de identificación parasitológica: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de identificación parasitaria

El estudio de los parásitos, sus hospedadores y sus interacciones se conoce como parasitología. En cuanto a la biología, la parasitología se centra más en cómo viven los parásitos que en los organismos o entornos estudiados. Por tanto, incorpora ideas de diversas disciplinas y aplica métodos de disciplinas como la biología celular, la bioinformática, la bioquímica, la biología molecular, la inmunología, la genética, la evolución y la ecología.

Data Bridge Market Research analiza que el mercado de identificación parasitaria, valorado en USD 4.092,15 millones en 2022, alcanzará los USD 6.522,27 millones en 2030, creciendo a una CAGR del 6% durante el período de pronóstico de 2023 a 2030. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología de pacientes, análisis de canalización, análisis de precios y marco regulatorio.

Segmentación y alcance del mercado de identificación parasitológica      

Definición de mercado

El estudio de los parásitos, sus hospedadores y sus interacciones se conoce como parasitología. En la relación simbiótica conocida como parasitismo, un organismo, el parásito, obtiene una ventaja a expensas de otro, el hospedador, que suele ser un organismo de una especie diferente. La asociación también podría ser perjudicial para el hospedador. El enfoque de la parasitología como campo biológico no se centra en el organismo o el entorno en cuestión, sino en cómo viven. Como resultado, sintetiza el conocimiento de varias disciplinas e incorpora métodos de varias disciplinas científicas, incluidas la biología celular, la bioinformática, la bioquímica, la biología molecular, la inmunología, la genética, la evolución y la ecología.  

Dinámica del mercado de identificación parasitaria

Conductores

• La rápida expansión de las herramientas de diagnóstico impulsa la demanda

La demanda del mercado de identificación parasitaria ha aumentado en los países desarrollados y en desarrollo debido al aumento de las iniciativas estratégicas de los actores de todo el mundo para mejorar los sistemas de atención sanitaria. Las herramientas de diagnóstico rápido para detectar y tratar enfermedades infecciosas y parasitarias, el aumento de los ingresos disponibles y la identificación parasitaria contribuyen al crecimiento del mercado de identificación parasitaria. El mercado crecerá durante el período previsto debido a la iniciativa estratégica para promover la identificación parasitaria y explorar los mercados emergentes.

• Las técnicas modernas permiten la expansión del mercado

Parasite diagnosis requires parasite isolation with culture, expansion, and subsequent sequence testing. Significant concerns exist about the requirement for state-of-the-art tools for identifying parasitic strains due to the widespread infections caused by various pathogen types, such as protozoans, helminths, and ectoparasites. Numerous conventional techniques have been employed for years to identify parasitic strains. In diagnostic labs, advanced, contemporary methods that are more accurate and sensitive have also been used. Modern techniques such as MALDI-TOF MS, Rapid Diagnostic tests, and others are considered for a quick and precise diagnosis of the parasitic strain, which further fuels the market.

Opportunities

• Government initiatives lead to market segment expansion

The government is also making efforts to raise awareness of different parasitic infections. Additionally, government organizations are launching campaigns in developing nations to diagnose and treat diseases. For instance, the government of Japan set up three research and training centers to combat parasitic diseases after the global parasite control initiative was proposed. Governmental organizations' investments are also accelerating market expansion in the area.

• Technological progress enables market expansion

Fecal identification, morphological identification, immunological techniques, molecular techniques, rapid diagnostic tests (RDTS), MALDI-TOF MS, and other procedures are the most frequently used techniques for parasitology identification. Rising parasite testing rates, expanding federal body awareness campaigns globally, growing smartphone usage for parasite identification, and emerging technological trends are all expected to expand the parasitology identification market.

Restraints/Challenges

• Expensive detection restricts the market

Molecule-based identification methods are accurate, sensitive, and susceptible. Additionally, the high cost of the devices, RT PCR, and MALDI-TOF are two major molecular technique drawbacks. The utility in developing countries is constrained, and the development of pricy detection devices is limited. With factors such as the rise in chronic infectious diseases, increased government involvement, and the use of machine learning and artificial intelligence for parasite detection and diagnosis, the market for parasite identification is expanding. Higher diagnostic costs and incorrect data interpretation could hamper the market expansion during the forecasting period.

• Labor- and time-intensive processes may limit growth

The typical parasite identification technique uses a microscope. Using microscopes, parasites can be found in samples of blood smears, feces, lymph node aspirates, tissues, or cerebrospinal fluid; however, sample preparation for observation under microscopes is labor-intensive and time-consuming, which restricts the growth of the field.

This parasitology identification market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the parasitology identification market contact Data Bridge Market Research for an analyst brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2020, Abbott conducted a malaria study in the Mpigi district using its most recent rapid diagnostic malaria kit and the standard test currently available on the market. Abbott's quick diagnostic test showed some ground-breaking results, with a doubled positivity rate compared to the standard test. This has improved the company's brand value in the marketplace.
• In 2020, BD received approval for its automated flow cytometer system, the BD FACSDUET. By increasing accuracy and standardization from instrument to instrument and operator to operator, automation solutions for flow cytometry like the BD FACSDuetTM and BD FACSLyricTM Complete Sample-to-Answer Solution help to increase throughput and provide consistent results that clinicians rely on to guide patient care.

Global Parasitology Identification Market Scope

The parasitology identification market is segmented on the basis of product, method, pathogen type, sample, stool concentration and preparation, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Products

• Consumables and Accessories
• Devices
• Polymerase Chain Reaction (PCR)
• Madd Spectrometers
• Microscopes
• Polystrainers
• Flow Cytometers
• Others

Methods

• Microscopic ideantification
• Fecal Identification
• Immunological Techniques
• Enzyme linked immunosorbent Assay (ELISA)
• Heamaggulutination Assay
• Others
• Morphological Identification
• Molecular Techniques
• Rapid Diagnostic Tests (RDTs)
• Maldi-TOF MS
• Others

Pathogen Type

• Protozoan
• Helminths
• Arthropodes
• Tapeworm
• Ectoparast

Sample

• Feces
• Blood
• Urine
• Cerebrospinal fluid (CSF)
• Serum and Plasma
• Others

Stool Concentration and Preparation

• Concentration Technique
• Un-Concentration Technique

End User

• Diagnostic Centers
• Hospitals
• Clinics
• Ambulatory surgical centers
• Others

Global Parasitology Identification Market Regional Analysis/Insights

The parasitology identification market is analysed and market size insights and trends are provided by country, product, method, pathogen type, sample, stool concentration and preparation, and end user as referenced above.

The countries covered in the parasitology identification market report are  U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market and will continue to flourish its trend of dominance during the forecast period. The major factors attributable to the region’s dominance are the largest consumer market and high gross domestic product are present. The U.S., which dominates the parasitology identification market in North America, is anticipated to grow at a CAGR over the course of the forecast period due to factors including rising healthcare costs, increased parasitology-related research and development, and trending diagnostic tool advancements.

Asia-Pacific will undergo the highest growth rate during the forecast period owing upgradation of medical infrastructure-driven parasitology identification and federal bodies’ initiatives. China is expected to dominate in the market in the Asia-Pacific market. With its rapidly rising product usage and advancements in parasitology identification, China is one of the top nations in the world.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Parasitology Identification Market Share Analysis

The parasitology identification market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to parasitology identification market.

Some of the major players operating in the parasitology identification market are:

• Abbott (U.S.)
• BD (U.S.)
• bioMérieux, Inc.(France)
• Bruker (U.S.)
• Quest Diagnostics (Estados Unidos)
• Akron Biotech (Estados Unidos)
• Thermo Fisher Scientific Inc (Estados Unidos)
• Altona Diagnostics GmbH (Alemania)
• Biomerica (Estados Unidos)
• Laboratorios Bio-Rad, Inc. (Estados Unidos)
• Diagnóstico creativo (Estados Unidos)
• Corporación Luminex (Estados Unidos)
• Meridian Bioscience, Inc. (Estados Unidos)
• R-Biopharm AG (Alemania)
• Corporación Shimadzu (Japón)
• Instituto Virion/Serion (Alemania)
• VWR International, LLC. (Estados Unidos)
• Hardy Diagnostics (Estados Unidos)
• TECHLAB, Inc. (Estados Unidos)
• Alpha-Tec (Estados Unidos)
• Corporación Médica Química (MCC). (Estados Unidos)

SKU-44731